Testing Services
Epidermal Nerve Fiber Density Testing
Onychodystrophy Testing
Pharmacogenetic Testing
EPIDERMAL NERVE FIBER DENSITY TESTING
The National Institute of Neurological Disorders and Stroke estimates that more than 20 million people in the United States are affected by peripheral neuropathy.
The following conditions are associated with peripheral neuropathy
-
Diabetes
-
Hyperlipidemia
-
Thyroid dysfunction
-
Chronic alcohol abuse
-
Neurotoxic drug exposure
-
Immune-mediated conditions
-
Metabolic syndrome
-
Chemotherapy
-
Autoinflammatory diseases
-
Hepatitis C
-
Lyme disease
-
Vitamin B12 deficiency
*A large number of cases have an unidentifiable cause
PHARMACOGENETIC TESTING
World Health Organization
According to the WHO, over 50% of harm in healthcare is preventable, with half of this harm attributed to medications
Our genetic panel can assist healthcare providers with personalized medication and dosing recommendations for
-
Diabetes
-
Infectious disease
-
Gastrointestinal disorders
-
Cardiovascular disease
-
Pain management
-
Psychiatric disorders & addiction
-
Mental health (ADHD)
ONYCHODYSTROPHY TESTING
Centers for Disease Control and Prevention
"When possible, test for fungal disease before prescribing treatment." - CDC
Our advanced test methods detect genus and species for fungi, yeast, and bacteria that can cause onychodystrophy. Risk factors for developing a nail infection include:
-
Older age
-
Minor skin or nail injury
-
Weakened immune system
-
Recurrent nail trauma
-
Poor circulation
-
Diabetes
-
Skin condition that affects the nail (psoriasis)
-
Tobacco use
-
Peripheral vascular disease